358 results on '"Phillips, Gordon L."'
Search Results
2. Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival
3. Hematopoietic Cell Transplantation
4. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review
5. Role of Hematopoietic Stem Cell Transplantation in the Treatment of Non-Hodgkin’s Lymphoma
6. A Phase 1 Trial of Eltrombopag in Patients Undergoing Stem Cell Transplantation after Total Body Irradiation
7. A phase I study of decitabine and rapamycin in relapsed/refractory AML
8. A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia
9. The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation
10. Outlook
11. Pulmonary Problems
12. Secondary Malignancies
13. Neuroendocrine Function, Growth and Development
14. Chronic Graft-Versus-Host Disease
15. Treatment Planning and Timing of Transplantation
16. Introduction
17. Follow-Up after Discharge from the Transplant Center
18. Acute Graft-Versus-Host Disease (GVHD)
19. Central Nervous System
20. Side Effects of Conditioning Regimens
21. Kidneys and Urinary Tract
22. Interstitial Pneumonitis
23. Hepatic Dysfunction
24. Marrow Graft Failure
25. Management of Infections
26. Conditioning Regimens
27. Collection, Processing and Infusion of Marrow
28. Preparation for Marrow Transplantation
29. Donor Selection
30. Improved outcomes in acute myeloid leukemia patients treated with washed transfusions
31. Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): How can we improve outcomes in the near future?
32. A Phase I Trial: Dose Escalation of Melphalan in the “BEAM” Regimen Using Amifostine Cytoprotection
33. Other Delayed Complications
34. Rehabilitation
35. Ophthalmologic Problems
36. Cost and Availability of Transplantation
37. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia
38. Patterns and Timing of Initial Relapse in Patients Subsequently Undergoing Transplantation for Hodgkin's Lymphoma
39. Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement
40. New cancer therapies. Are haematopoietic cell transplants a dead duck?
41. Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020
42. Pretransplantation Consolidation Chemotherapy Decreases Leukemia Relapse after Autologous Blood and Bone Marrow Transplants for Acute Myelogenous Leukemia in First Remission
43. Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia
44. Role of Hematopoietic Stem Cell Transplantation in the Treatment of Non-Hodgkin’s Lymphoma
45. Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease
46. High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver
47. How Do We Define Cure of Diabetes?
48. Gas-chromatographic analysis of busulfan for therapeutic drug monitoring
49. A Guide to Blood and Marrow Transplantation
50. Use of the Anti-idiotype Breast Cancer Vaccine 11D10 in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.